Nomura Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.16M | Sell |
48,973
-8,937
| -15% | -$1.12M | 0.02% | 550 |
|
|
2025
Q1 | $6.4M | Buy |
57,910
+4,284
| +8% | +$474K | 0.02% | 529 |
|
|
2024
Q4 | $7.32M | Sell |
53,626
-2,649
| -5% | -$362K | 0.02% | 490 |
|
|
2024
Q3 | $6.48M | Sell |
56,275
-1,473
| -3% | -$170K | 0.02% | 510 |
|
|
2024
Q2 | $7.95M | Sell |
57,748
-5,434
| -9% | -$748K | 0.03% | 428 |
|
|
2024
Q1 | $8.71M | Sell |
63,182
-423
| -0.7% | -$58.3K | 0.03% | 410 |
|
|
2023
Q4 | $8.38M | Buy |
63,605
+100
| +0.2% | +$13.2K | 0.03% | 404 |
|
|
2023
Q3 | $7.14M | Sell |
63,505
-5,580
| -8% | -$628K | 0.03% | 418 |
|
|
2023
Q2 | $6.51M | Buy |
69,085
+100
| +0.1% | +$9.43K | 0.03% | 444 |
|
|
2023
Q1 | $6.98M | Buy |
68,985
+32,756
| +90% | +$3.32M | 0.04% | 419 |
|
|
2022
Q4 | $4.33M | Buy |
36,229
+2,200
| +6% | +$263K | 0.03% | 490 |
|
|
2022
Q3 | $3.61M | Hold |
34,029
| – | – | 0.02% | 505 |
|
|
2022
Q2 | $3.32M | Buy |
34,029
+2,100
| +7% | +$205K | 0.02% | 565 |
|
|
2022
Q1 | $2.99M | Hold |
31,929
| – | – | 0.02% | 631 |
|
|
2021
Q4 | $2.72M | Buy |
31,929
+13,529
| +74% | +$1.15M | 0.01% | 671 |
|
|
2021
Q3 | $1.76M | Sell |
18,400
-13,209
| -42% | -$1.27M | 0.01% | 738 |
|
|
2021
Q2 | $3.08M | Buy |
31,609
+1,327
| +4% | +$129K | 0.02% | 617 |
|
|
2021
Q1 | $2.94M | Sell |
30,282
-1,082
| -3% | -$105K | 0.02% | 593 |
|
|
2020
Q4 | $3.01M | Buy |
31,364
+429
| +1% | +$41.1K | 0.02% | 565 |
|
|
2020
Q3 | $2.98M | Hold |
30,935
| – | – | 0.02% | 492 |
|
|
2020
Q2 | $3.78M | Buy |
30,935
+1,304
| +4% | +$159K | 0.03% | 417 |
|
|
2020
Q1 | $2.57M | Buy |
29,631
+1,400
| +5% | +$121K | 0.03% | 447 |
|
|
2019
Q4 | $3.04M | Buy |
28,231
+13,620
| +93% | +$1.46M | 0.03% | 475 |
|
|
2019
Q3 | $1.32M | Hold |
14,611
| – | – | 0.01% | 717 |
|
|
2019
Q2 | $1.23M | Hold |
14,611
| – | – | 0.01% | 725 |
|
|
2019
Q1 | $1.29M | Hold |
14,611
| – | – | 0.01% | 696 |
|
|
2018
Q4 | $1.04M | Hold |
14,611
| – | – | 0.01% | 688 |
|
|
2018
Q3 | $1.8M | Hold |
14,611
| – | – | 0.02% | 583 |
|
|
2018
Q2 | $1.44M | Hold |
14,611
| – | – | 0.01% | 650 |
|
|
2018
Q1 | $1.21M | Hold |
14,611
| – | – | 0.01% | 675 |
|
|
2017
Q4 | $1.13M | Hold |
14,611
| – | – | 0.01% | 694 |
|
|
2017
Q3 | $895K | Hold |
14,611
| – | – | 0.01% | 716 |
|
|
2017
Q2 | $672K | Hold |
14,611
| – | – | 0.01% | 782 |
|
|
2017
Q1 | $633K | Hold |
14,611
| – | – | 0.01% | 788 |
|
|
2016
Q4 | $565K | Hold |
14,611
| – | – | 0.01% | 805 |
|
|
2016
Q3 | $740K | Hold |
14,611
| – | – | 0.01% | 743 |
|
|
2016
Q2 | $664K | Sell |
14,611
-7,281
| -33% | -$331K | 0.01% | 745 |
|
|
2016
Q1 | $866K | Buy |
+21,892
| New | +$866K | 0.02% | 670 |
|